neuronetics

Description

Neuronetics collects personally identifiable information through the Site, such as your name, age, e-mail, telephone number, mailing address and other, similar information (“Personal Data”). Your submission of Personal Data is entirely voluntary. However, if you desire to take advantage of certain services, information and materials provided to registered users of the Site, you will be required to register, and in registering will be required to provide us with Personal Data.

Our goal moving forward is to partner with healthcare professionals by providing them the best products and services possible. We are committed to continuous product improvement and to developing new and innovative solutions to meet our customers’ needs. By providing these tools, we can help healthcare professionals achieve their ultimate goal of effectively treating the patients they serve.

We may share Personal Data with agents, affiliates, contractors or business partners of Neuronetics in connection with services that these individuals or entities perform for, or with, Neuronetics. These agents, affiliates, contractors or business partners have agreed to use Personal Data only to provide services for Neuronetics. For example, we may provide Personal Data to an entity that hosts our business databases,or that provides data processing services for us, or so that we can send you information that you have requested from us.

Neuronetics, Inc. is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. We are the first company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant medication * . Based in Malvern, PA, we are the leader in the development of NeuroStar TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.

Since completing clinical trials, our experienced Product Development group has continued to refine our early research device to develop a high quality, efficient, user friendly commercial unit – the NeuroStar TMS Therapy ® system.

Fact sheet

Companies nearby